Skip to main content

Table 2 Interventions and outcomes of the study cohort

From: Hospitals with and without neurosurgery: a comparative study evaluating the outcome of patients with traumatic brain injury

Variables

NSH

No NSH

P valuea

All

Matched (1:3)

Interventions in ICUs—N (%)

 Hypothermia

93 (1.4)

5 (0.7)

1 (0.4)

0.636

 External ventricular drainage without ICP monitoring

92 (1.4)

2 (0.3)

1 (0.4)

0.738

 External ventricular drainage with ICP monitoringb

398 (6.0)

31 (4.5)

0 (0.0)

0.001

 Barbiturate infusion for refractory ICP

393 (5.9)

18 (2.6)

1 (0.4)

0.045

 Hyperventilation paCO2 < 25 mmHg

312 (4.7)

17 (2.4)

9 (3.9)

0.251

 Indomethacin

23 (0.3)

0 (0.0)

0 (0.0)

1.000

 Mannitol (multiple doses)

1613 (24.1)

119 (17.1)

43 (18.5)

0.618

 Hypertonic saline

816 (12.2)

46 (6.6)

15 (6.5)

0.939

 Invasive monitoring of intracranial pressurec

1930 (28.9)

105 (15.1)

6 (2.6)

< 0.001

Complications during ICU stay—N (%)

 Cardiovascular

693 (10.4)

59 (8.5)

14 (6.0)

0.231

 Gastrointestinal

197 (2.9)

17 (2.4)

3 (1.3)

0.296

 Neurologicald

2438 (36.5)

179 (25.7)

74 (31.9)

0.067

 Respiratory

954 (14.3)

90 (12.9)

12 (5.2)

0.001

 Other

325 (4.9)

24 (3.4)

3 (1.3)

0.091

 Infections

2423 (36.3)

193 (27.7)

44 (19.0)

0.008

 Missing

2

0

0

 

Three-day mortality—N deaths (%)

836 (12.5)

66 (9.5)

18 (7.8)

0.428

 Missing

2

0

0

 

ICU outcome

Dead—N (%)

1569 (23.5)

143 (20.5)

67 (28.9)

0.009

 Missing vital status

7

0

0

 

If alive, conditions at discharge:

0.674

 Follow simple commands—N (% on alive)

1443 (28.5)

116 (21.3)

32 (19.8)

 

 Cannot follow simple commands—N (% on alive)

3607 (71.5)

429 (78.7)

130 (80.2)

 

 Missing conditions at discharge

63

8

3

 

If alive, discharged to:

< 0.001

 Ward—N (% on alive)

2283 (44.7)

282 (51.0)

115 (69.7)

 

 Other ICU—N (% on alive)

1167 (22.9)

113 (20.4)

26 (15.8)

 

 High dependency unit—N (% on alive)

1276 (25.0)

137 (24.8)

16 (9.7)

 

 Rehabilitation—N (% on alive)

358 (7.0)

20 (3.6)

2 (1.2)

 

 Day hospital or long-term care—N (% on alive)

5 (0.1)

1 (0.2)

5 (3.0)

 

 Home—N (% on alive)

17 (0.3)

0 (0.0)

1 (0.6)

 

Hospital mortality—N deaths (%)

2054 (30.9)

194 (28.0)

82 (35.5)

0.030

 Missing

41

2

1

 

ICU stay (days)—Median (Q1–Q3)

 Alive after ICU

9.0 (3.0–18.0)

5.0 (2.0–13.0)

4.0 (2.0–12.0)

0.872

 Deaths in ICU

3.0 (1.0–7.0)

3.0 (1.0–7.0)

5.0 (2.0–10.0)

0.049

 Missing

2

1

0

 

Hospital stay (days)—Median (Q1–Q3)

 Alive after ICU

19.0 (10.0–34.0)

16.0 (9.0–.0)

14.0 (7.0–25.0)

0.130

 Missing

17

0

0

 

6-month GOS-E—N (%)

0.010

 Severe disability pre-TBI

86 (1.6)

17 (3.2)

4 (2.1)

 

 Moderate disability pre-TBI

53 (1.0)

4 (0.7)

0 (0.0)

 

 Dead (1)

2308 (42.6)

228 (42.3)

87 (46.5)

 

 Vegetative State (2)

174 (3.2)

12 (2.2)

4 (2.1)

 

 Lower severe disability (3)

748 (13.8)

76 (14.1)

20 (10.7)

 

 Upper severe disability (4)

407 (7.5)

43 (8.0)

11 (5.9)

 

 Lower moderate disability (5)

267 (4.9)

21 (3.9)

2 (1.1)

 

 Upper moderate disability (6)

428 (7.9)

38 (7.1)

9 (4.8)

 

 Lower good recovery (7)

427 (7.9)

44 (8.2)

10 (5.3)

 

 Upper good recovery (8)

514 (9.5)

56 (10.4)

40 (21.4)

 

 Missing

1270

157

45

 
  1. aP-value comparing no-NSH and matched NSH patients
  2. bIntraventricular catheter for both intracranial pressure monitoring and drainage of cerebral spinal fluid
  3. cInvasive monitoring of intracranial pressure includes subdural, subarachnoid, intraparenchymal, intraventricular probe insertion for the sole intracranial pressure monitoring
  4. dNeurological complications include intracranial hypertension, episodes of dilated pupils unreactive to light and brain edema